Risk of leukemia in first degree relatives of patients with nonsyndromic cleft lip and palate

Eduardo Gonçalves1, Daniella Reis Barbosa Martelli1, Ricardo Della Coletta2

  • 1Universidade Estadual de Montes Claros, Montes Claros, MG, Brazil.

Brazilian Oral Research
|October 23, 2014
PubMed

Insights

This study investigated leukemia in parents of children with nonsyndromic cleft lip and/or palate (NSCL/P). Results show no significant increase in leukemia history among parents of NSCL/P patients compared to controls.

Area of Science:

  • Genetics
  • Pediatrics
  • Oncology

Background:

  • Nonsyndromic cleft lip and/or cleft palate (NSCL/P) are common congenital anomalies.
  • The etiology of NSCL/P is multifactorial, involving genetic and environmental factors.
  • Understanding familial risks for other conditions in NSCL/P families is important.

Purpose of the Study:

  • To determine the frequency of leukemia in parents of patients with NSCL/P.
  • To assess if a family history of leukemia is more common in relatives of NSCL/P patients.

Main Methods:

  • A case-control study design was employed.
  • Evaluated first-degree family members of 358 NSCL/P patients and 1,432 controls.
  • Fisher's exact test was used for statistical analysis.

Main Results:

  • Three parents of NSCL/P patients reported a history of leukemia.
  • Two control subjects had a family history of leukemia.
  • No statistically significant difference in leukemia history was observed between the groups.

Conclusions:

  • The frequency of leukemia in parents of NSCL/P patients is not significantly elevated.
  • This study does not support an increased familial risk of leukemia in NSCL/P kindreds.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.9K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.2K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K